公开(公告)号：US20200237757A1

公开(公告)日：2020-07-30

申请号：US16303539

申请日：2017-05-23

申请人： BAYER PHARMA AKTIENGESELLSCHAFT ,  DEUTSCHES KREBSFORSCHUNGSZENTRUM (DKFZ)

发明人： Norbert SCHMEES ,  Ilona GUTCHER ,  Horst IRLBACHER ,  Benjamin BADER ,  Na ZHAO ,  Michael PLATTEN ,  Ulrike ROEHN ,  Ludwig ZORN ,  Lars ROESE ,  Detlef STOECKIGT

IPC分类号： A61K31/501 ,  A61K45/06 ,  C07D237/24 ,  C07D405/12 ,  C07D403/12 ,  A61K31/50 ,  A61P35/00

摘要： The present invention covers 3-oxo-2,6-diphenyl-2,3-dihydropyridazine-4-carboxamide compounds of general formula (I): in which R1, R2, R3, R4, R5 and R6 are as defined herein, methods of preparing said compounds, intermediate compounds useful for preparing said compounds, pharmaceutical compositions and combinations comprising said compounds and the use of said compounds for manufacturing pharmaceutical compositions for the treatment or prophylaxis of diseases, in particular of cancer or conditions with 10 dysregulated immune responses or other disorders associated with aberrant AHR signaling, as a sole agent or in combination with other active ingredients.